Erytech Pharma | Ownership
Companies that own Erytech Pharma
BVF Partners LP
3,005,662
16.76%
193,435
2.18%
07/18/2018
Baker Bros. Advisors LP
2,000,000
11.15%
191,732
0.14%
06/29/2018
JPMorgan Asset Management (UK) Ltd.
586,077
3.27%
-73,437
0.01%
08/23/2017
Allianz Global Investors GmbH
418,817
2.34%
0
0.01%
05/31/2018
Norges Bank Investment Management
179,203
1%
49,999
0%
12/31/2017
APG Asset Management NV
117,647
0.66%
-11,440
0%
03/31/2018
OFI Asset Management SA
68,497
0.38%
-5,389
0.01%
05/31/2018
Aramea Asset Management AG
60,000
0.34%
20,000
0.16%
09/30/2017
Etoile Gestion SA
57,407
0.32%
0
0.02%
01/31/2018
Chaussier Gestion SA
38,500
0.22%
38,500
0.47%
12/29/2017
| Address |
Bâtiment Adénine
Lyon Rhone-Alpes 69008
France
|
|
Employees
|
- |
| Website |
http://www.erytech.com |
| Updated |
07/08/2019 |
| ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. |
